Patents by Inventor Eiko Takao

Eiko Takao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7037700
    Abstract: Reagents that regulate human ceramide kinase protein activity and reagents that bind to human ceramide kinase gene products can be used to regulate intracellular signaling and consequently cell proliferation and apoptosis. Such regulation is particularly useful for treating allergies including but not limited to asthma, autoimmune diseases such as rheumatoid arthritis, inflammatory disease, transplant rejection, and cancer, particularly lymphocytic leukemias, and could be a useful target of vaccination enhancing adjuvants. Central and peripheral nervous system disorders, such as Parkinson's disease, also can be treated.
    Type: Grant
    Filed: December 19, 2003
    Date of Patent: May 2, 2006
    Assignee: Bayer Aktiengesellschaft
    Inventors: Sophia Kossida, Jeffrey Encinas, Eiko Takao
  • Publication number: 20040192580
    Abstract: Reagents that regulate human ceramide kinase protein activity and reagents that bind to human ceramide kinase gene products can be used to regulate intracellular signaling and consequently cell proliferation and apoptosis. Such regulation is particularly useful for treating allergies including but not limited to asthma, autoimmune diseases such as rheumatoid arthritis, inflammatory disease, transplant rejection, and cancer, particularly lymphocytic leukemias, and could be a useful target of vaccination enhancing adjuvants. Central and peripheral nervous system disorders, such as Parkinson's disease, also can be treated.
    Type: Application
    Filed: December 19, 2003
    Publication date: September 30, 2004
    Applicant: Bayer Aktiengesellschaft
    Inventors: Sophia Kossida, Jeffrey Encinas, Eiko Takao